These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11132311)

  • 1. [Challenge for the general practitioner. Sufficient therapy for heart failure].
    Füessl HS
    MMW Fortschr Med; 2000 Nov; 142(46):4-8. PubMed ID: 11132311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of ischemic and nonischemic heart failure. Current status and prospects].
    Weil J; Riegger G
    Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003
    [No Abstract]   [Full Text] [Related]  

  • 3. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Essential basics in therapy of heart failure. Without diuretics the prognosis is poor].
    Bischoff A
    MMW Fortschr Med; 2002 Jul; 144(29-30):6-8. PubMed ID: 12219622
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of chronic cardiac decompensation].
    van Zanten RA; Laird-Meeter K
    Ned Tijdschr Geneeskd; 1987 Apr; 131(15):615-8. PubMed ID: 3574530
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of heart failure. Take the chance!].
    Einecke D
    MMW Fortschr Med; 2001 Sep; 143(38):8-10, 12. PubMed ID: 11601101
    [No Abstract]   [Full Text] [Related]  

  • 7. Vesnarinone for heart failure.
    Neely D
    N Engl J Med; 1994 Jan; 330(1):65. PubMed ID: 8259152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catecholamines use in patients with heart failure].
    Iino K; Ito H
    Nihon Rinsho; 2007 May; 65 Suppl 5():30-3. PubMed ID: 17571362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peculiarities of cardiovascular pharmacotherapy in the neonatal period].
    Hruda J; Samánek M
    Cesk Pediatr; 1986 Apr; 41(4):215-7. PubMed ID: 3719804
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
    Stevenson LW
    Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypertension and heart failure. Are there approaches for differential therapy?].
    Böhm M
    MMW Fortschr Med; 2000 Feb; 142(7):31-3. PubMed ID: 10832331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe heart failure: balancing length and quality of life.
    Harv Heart Lett; 1999 Jun; 9(10):1-2. PubMed ID: 10233785
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of heart failure. Is phytotherapy effective?].
    MMW Fortschr Med; 2001 Jun; 143(25):59. PubMed ID: 11469004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardio-geriatric polypragmatism. Pharmacotherapy in the elderly: "individual experiments"].
    MMW Fortschr Med; 2005 Jun; 147(23):8, 11. PubMed ID: 15981897
    [No Abstract]   [Full Text] [Related]  

  • 15. [Why are results of studies with digitalis so poor? "It depends on potassium!"].
    Hien M
    MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for dying among ibopamine users].
    de Graeff PA; Elferink AJ; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 May; 143(21):1114-5. PubMed ID: 10368748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lower digitalis dosage in heart failure].
    Madsen S; Holene E
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1053-4. PubMed ID: 17457392
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.